Literature DB >> 9426425

Estrogen receptor gene polymorphism in postmenopausal primary hyperparathyroidism.

T Carling1, J Rastad, A Kindmark, E Lundgren, S Ljunghall, G Akerström.   

Abstract

BACKGROUND: Estrogen and its receptor play a key role in calcium homeostasis, with implications in both the development and treatment of primary hyperparathyroidism.
METHODS: Leukocyte DNA was isolated from 101 postmenopausal female patients with primary hyperparathyroidism and age-matched female control subjects (n = 101). Polymorphic estrogen receptor alleles denoted P/p and X/x were detected by polymerase chain reaction and restriction digestion with Pvu II and Xba 1
RESULTS: Allelic prevalences were similar in the patients and control subjects. In contrast to normocalcemic control subjects, patients with primary hyperthyroidism homozygous for alleles P and X displayed less elevated serum calcium concentrations (mean, 2.63 and 2.66 mmol/L) versus those with Pp and pp (2.72 mmol/L; p < 0.01) and Xx and xx (2.71; p < 0.05), respectively, as well as trends for higher intact serum parathyroid hormone values (p = 0.09). The PP genotype was accompanied by lower bone mineral density in the lumbar spine (p < 0.05).
CONCLUSIONS: Estrogen receptor gene polymorphisms are presumably not directly involved in the parathyroid tumorigenesis. However, they seem to interact with the extent of biochemical derangements of primary hyperthyroidism by possible influences on both the peripheral action of parathyroid hormone and calcium regulation of its secretion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9426425     DOI: 10.1016/s0039-6060(97)90214-2

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  7 in total

1.  Association between ER-α polymorphisms and bone mineral density in patients with Turner syndrome subjected to estroprogestagen treatment--a pilot study.

Authors:  Elżbieta Sowińska-Przepiera; Elżbieta Andrysiak-Mamos; Kornel Chełstowski; Grażyna Adler; Zbigniew Friebe; Anhelli Syrenicz
Journal:  J Bone Miner Metab       Date:  2011-01-27       Impact factor: 2.626

2.  Association of estrogen receptor alpha gene polymorphisms with cytokine genes expression in systemic lupus erythematosus.

Authors:  Zhi-Ming Lu; Zi-E Wang; Yi-Qing Liu; Chun-Xiao Wu; Chang-Yin Wang; Bing-Chang Zhang; Song Shao; Yu-Lian Jiao; Zhi-Xiang Che; Zi-Jiang Chen; Yue-Ran Zhao
Journal:  Croat Med J       Date:  2009-04       Impact factor: 1.351

3.  Renal stone disease, elevated iPTH level and normocalcemia.

Authors:  Nada B Dimkovic; Abdul Aziz Wallele; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

4.  Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism.

Authors:  F Cetani; S Borsari; E Vignali; E Pardi; A Picone; L Cianferotti; G Rossi; P Miccoli; A Pinchera; C Marcocci
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

Review 5.  The G allele of CaSR R990G polymorphism increases susceptibility to urolithiasis and hypercalciuria: evidences from a comprehensive meta-analysis.

Authors:  Kang Liu; Xiaolan Wang; Jiaxin Ye; Chao Qin; Pengfei Shao; Wei Zhang; Jie Li; Changjun Yin
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

6.  PvuII and XbaI polymorphisms of estrogen receptor-α and the results of estroprogestagen therapy in girls with functional hypothalamic amenorrhea - preliminary study.

Authors:  Elżbieta Sowińska-Przepiera; Anhelli Syrenicz; Zbigniew Friebe; Grażyna Jarząbek-Bielecka; Kornel Chełstowski
Journal:  Arch Med Sci       Date:  2012-10-16       Impact factor: 3.318

Review 7.  Gender Predilection in Sporadic Parathyroid Adenomas.

Authors:  Maria P Yavropoulou; Athanasios D Anastasilakis; Argyro Panagiotakou; Evanthia Kassi; Polyzois Makras
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.